The Journal of Bone and Joint Surgery (American). 2007;89:668-671.
doi:10.2106/JBJS.F.01609
© 2007 The Journal of Bone and Joint Surgery, Inc.
Developmental Biology in OrthopaedicsSummary of the 2006 AAOS Research Symposium*
Benjamin A. Alman, MD1 and
William A. Horton, MD2
1 Division of Orthopaedic Surgery and Program in Developmental Biology, The
Hospital for Sick Children, 555 University Avenue, Toronto, ON M5G 1X8,
Canada
2 Oregon Health and Science University, Shriners Hospital for Children, 3101
S.W. Sam Jackson Park Road, Portland, OR 97239
| The first 150 words of the full text of this article appear below. |
 |
Introduction
|
|---|
During normal fetal development, a variety of cell-signaling pathways are
regulated in a coordinated manner so that cells can proliferate, move, and
even die off in an organized fashion that allows organs to develop. Over the
past decade, there have been tremendous advances in understanding how the
musculoskeletal system develops. Knowledge about these pathways and how they
regulate cell behavior can be applied to musculoskeletal pathologic conditions
and repair processes. Many of the pathways that are important in development
can be targeted therapeutically; interestingly, many such agents have been
identified by their teratologic potential. Identifying the role of these key
signaling pathways in musculoskeletal disorders carries strong potential to
rapidly identify new therapeutic approaches. Genetically modified organisms,
such as transgenic mice, are important tools in this work. Because these
organisms have genetic abnormalities from the start of development, they can
be used to study the role of genes or cell-signaling . . . [Full Text of this Article]

CiteULike Connotea Del.icio.us Facebook Technorati Twitter What's this?
|